Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

Clinical and Experimental Hypertension ◽

10.3109/10641963.2010.503299 ◽

2011 ◽

Vol 33 (6) ◽

pp. 366-372 ◽

Cited By ~ 8

Author(s):

Toshihiko Ishimitsu ◽

Eri Ohno ◽

Nobuyuki Nakano ◽

Satoshi Furukata ◽

Akira Akashiba ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: PP.17.160

10.1097/01.hjh.0000379086.40169.10 ◽

2010 ◽

Vol 28 ◽

pp. e297-e298

Author(s):

T Yokoi ◽

S Nakade ◽

H Masaki ◽

Y Komiyama ◽

M Masuda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

COMBINED EFFECTS OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN II RECEPTOR ANTAGONIST IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES

10.1097/00004872-201106001-00656 ◽

2011 ◽

Vol 29 ◽

pp. e236

Author(s):

T. Yokoi ◽

S. Nakade ◽

H. Masaki ◽

H. Takahashi

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

940 COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES-

10.1097/01.hjh.0000420851.56988.3d ◽

2012 ◽

Vol 30 ◽

pp. e271

Author(s):

Toyohiko Yokoi ◽

Junya Azuma ◽

Yukiyoshi Nakade ◽

Fumihiro Sanada ◽

Kazuma Iekushi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp39417 ◽

2009 ◽

Author(s):

K. Ohnishi ◽

M. Kohno ◽

K. Yukiiri ◽

H. Masugata ◽

Y. Wada ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Metabolic Effects ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Elderly Hypertensive ◽

Elderly Hypertensive Patients

506 COMPARISON OF THE EFFECT OF COMBINATION THERAPY WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND EITHER LOW-DOSE DIURETICS OR A CALCIUM CHANNEL BLOCKER ON CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH CARDIAC HYPERTROPHY

10.1097/01.hjh.0000420361.84667.a8 ◽

2012 ◽

Vol 30 ◽

pp. e149

Author(s):

Takafumi Okura ◽

Ken-ichi Miyoshi ◽

Jun Irita ◽

Masanori Johtoku ◽

Tomoaki Nagao ◽

...

Keyword(s):

Angiotensin Ii ◽

Combination Therapy ◽

Cardiac Hypertrophy ◽

Calcium Channel ◽

Receptor Antagonist ◽

Low Dose ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

PS 14-47 COMBINED ANTIHYPERTENSIVE THERAPY WITH ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN PATIENTS WITH METABOLIC SYNDROME

10.1097/01.hjh.0000501169.72163.98 ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e447

Author(s):

Jamol Uzokov ◽

Anis Alyavi ◽

Sarvar Hojiev ◽

Davron Yaxshilikov ◽

Sarvar Dadaev

Keyword(s):

Metabolic Syndrome ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Equivalent blood pressure reduction with angiotensin ii receptor antagonist based therapy compared with a calcium channel blocker in mild-to-moderate hypertensive patients of african origin

American Journal of Hypertension ◽

10.1016/j.amjhyper.2004.03.303 ◽

2004 ◽

Vol 17 (5) ◽

pp. S116

Author(s):

E LIBHABER

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Channel Blocker ◽

Blood Pressure Reduction ◽

Pressure Reduction ◽

African Origin ◽

Angiotensin Ii Receptor ◽

Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease

European Journal of Pediatrics ◽

10.1007/s004310000495 ◽

2000 ◽

Vol 159 (8) ◽

pp. 590-593 ◽

Cited By ~ 20

Author(s):

Rodo O. von Vigier ◽

Priska M. Zberg ◽

Oliver Teuffel ◽

Mario G. Bianchetti

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Receptor Antagonist ◽

Angiotensin Ii Receptor ◽

Cost-effectiveness of renoprotection in diabetic patients with an angiotensin II receptor antagonist and a calcium channel blocker: economic analysis of the marval trial

American Journal of Hypertension ◽

10.1016/s0895-7061(03)00337-6 ◽

2003 ◽

Vol 16 (5) ◽

pp. A101

Author(s):

D SMITH

Keyword(s):

Cost Effectiveness ◽

Angiotensin Ii ◽

Economic Analysis ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽